Arrowstreet Capital’s iRadimed IRMD Stock Holding History

Arrowstreet Capital’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.8M	Buy	143,969 +128,524	+832%	+$11.7M	0.01%	981
2026 Q1	$1.49M	Buy	15,445 +9,136	+145%	+$914K	﹤0.01%	1466
2025 Q4	$614K	Buy	+6,309	New	+$541K	﹤0.01%	1650
2022 Q2	–	Sell	-17,149	Closed	-$769K	–	1327
2022 Q1	$769K	Sell	17,149 -821	-5%	-$38K	﹤0.01%	974
2021 Q4	$830K	Buy	+17,970	New	+$725K	﹤0.01%	1195
2018 Q4	–	Sell	-23,884	Closed	-$887K	–	1411
2018 Q3	$887K	Buy	+23,884	New	+$644K	﹤0.01%	821

Other funds holding IRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Arrowstreet Capital's IRMD Position: Q2 2026 in Review

Arrowstreet Capital increased its iRadimed (IRMD) stake by 832% in Q2 2026, buying an estimated $11.7M and bringing the position to 143,969 shares worth $13.8M. The position accounts for 0.01% of the portfolio, ranked #981.

Arrowstreet Capital first reported a position in IRMD in Q3 2018 and has held it in 6 quarters since. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

Arrowstreet Capital held 143,969 shares of iRadimed worth $13.8M as of Q2 2026.
Arrowstreet Capital bought 128,524 iRadimed shares in Q2 2026, an estimated $11.7M.
iRadimed made up 0.01% of Arrowstreet Capital's portfolio in Q2 2026, its #981 holding.
Arrowstreet Capital first reported a position in iRadimed in Q3 2018 and has held it in 6 quarters since.
214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.